Updated Review of Treatment for Female Androgenetic Alopecia

    April 2022 in “ Medicina estética ”
    Khawla Khashouf Maksoud
    Studysummary This review of female androgenetic alopecia treatments reports limited therapeutic options due to unclear pathogenesis, with minoxidil as the only FDA-approved treatment and adjuvant therapies under investigation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on seme.org →
    Discuss this study in the Community →